Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Robert, Delaune"'
Autor:
Lawrence E. Garbo, Lianchun Xiao, Brittany North, Ralph E. Weinstein, Ana Aparicio, Mark D. Fleming, William R. Berry, Guru Sonpavde, Feng Zhan, Lina Asmar, Kristi A. Boehm, Matthew D. Galsky, Steven R. Rousey, Robert Delaune, Daniel D. Von Hoff
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 29:682-689
Azacitidine is a hypomethylating agent that activates genes repressed by promoter methylation. Preclinically, demethylating agents reverse resistance of prostate cancer to androgen ablation. A phase II trial evaluated azacitidine for men with castrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::046f6bedb2b7edeac68e026bc49aff09
https://doi.org/10.1016/j.urolonc.2009.09.015
https://doi.org/10.1016/j.urolonc.2009.09.015
Autor:
Svetislava J. Vukelja, Robert L. Ruxer, Daniel Atienza, Thomas E. Hutson, Thomas F. Gregory, Robert Delaune, Robert N. Raju, Philip Y. Dien, William R. Berry, Margaret Deutsch, Joseph J. Muscato, Stephanie Mull, Steven J. Nicol, Sanjay Awasthi, Karen Hood, Des Ilegbodu, Michael J. Kolodziej
Publikováno v:
Investigational New Drugs. 26:151-158
Objectives: Gemcitabine (G) plus cisplatin (C) is standard care for metastatic transitional cell carcinoma (TCC) of the urothelium. Pemetrexed (P), alone or in combination with G, is active in metastatic TCC. However, the safety and efficacy of P com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6ab5008d0a8b4dbf3277b37b0461bde
https://doi.org/10.1007/s10637-007-9111-2
https://doi.org/10.1007/s10637-007-9111-2
Autor:
Scott H, Okuno, Robert, Delaune, Jeff A, Sloan, Nathan R, Foster, Matthew J, Maurer, Marie-Christine, Aubry, Kendrith M, Rowland, Gamini S, Soori, Daniel A, Nikcevich, Carl G, Kardinal, Donald W, Northfelt, Alex A, Adjei, Anthony J, Jaslowski
Publikováno v:
Cancer. 112:1772-1779
BACKGROUND. The North Central Cancer Treatment Group (NCCTG) conducted a phase 2 study to evaluate the antitumor activity of the combination of gemcitabine and epirubicin in patients with pleural mesothelioma who received no more than 1 prior chemoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7153acc26784fe7f8987de36d61e11b8
https://doi.org/10.1002/cncr.23313
https://doi.org/10.1002/cncr.23313
Autor:
Eduardo R. Pajon, Rui Qin, Smitha Menon, Diana Christian, Jeffrey L. Berenberg, Sachdev P. Thomas, Charles L. Loprinzi, Robert Delaune, Kendrith M. Rowland, Daniel Satele, Sherry L. Wolf
Purpose Hand-foot syndrome (HFS) is a dose-limiting toxicity of capecitabine for which no effective preventative treatment has been definitively demonstrated. This trial was conducted on the basis of preliminary data that a urea/lactic acid–based t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08b847553b539a1c3fe84508bd77b017
https://europepmc.org/articles/PMC3020691/
https://europepmc.org/articles/PMC3020691/
Autor:
Ralph E. Weinstein, Guru Sonpavde, Kristi A. Boehm, Lawrence Garbo, Robert Delaune, A. Williams, Ana Aparicio, Feng Zhan, Lina Asmar, D. D. Von Hoff, Steven R. Rousey
Publikováno v:
Journal of Clinical Oncology. 26:5172-5172
5172 Background: Vidaza (azacitidine, Pharmion Corp), a demethylating agent that activates genes repressed by promoter methylation, may induce responses in malignancies. Preclinically, demethylatin...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c733004142a6e0e9551c21d41fdb3d5c
https://doi.org/10.1200/jco.2008.26.15_suppl.5172
https://doi.org/10.1200/jco.2008.26.15_suppl.5172
Autor:
James A. Mailliard, Robert Delaune, Nathan R. Foster, Brian M. Bot, Marie Christine Aubry, Jeff A. Sloan, James R. Jett, Scott H. Okuno, Daniel A. Nikcevich, Kendrith M. Rowland
Publikováno v:
Journal of Clinical Oncology. 23:7264-7264
7264 Background: MPM is a relentlessly progressive disease. Optimal chemotherapy for MPM is unknown, but there is preclinical evidence of cytotoxic synergy between gemcitabine (G) and epirubicin (E...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94101aece859be4ab1e6f8a794f9b712
https://doi.org/10.1200/jco.2005.23.16_suppl.7264
https://doi.org/10.1200/jco.2005.23.16_suppl.7264